Effect of abrocitinib in a patient with extensive necrobiosis lipoidica

J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1208-e1210. doi: 10.1111/jdv.19189. Epub 2023 May 18.

Authors

L Arnet¹, C Erfurt-Berge¹

Affiliation

¹ Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

PMID: 37170953
DOI: 10.1111/jdv.19189

No abstract available

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 1*
Humans
Necrobiosis Lipoidica* / complications
Necrobiosis Lipoidica* / drug therapy
Pyrimidines
Sulfonamides

Substances

abrocitinib
Pyrimidines
Sulfonamides